Wrap Text
ASPI to host business update conference call on April 13, 2026, at 8:00 AM ET
ASP ISOTOPES INC.
(Incorporated in the State of Delaware,
United States of America)
(Delaware file number 6228898)
Ticker Symbol: NASDAQ: ASPI
ISIN: US00218A1051
LEI: 6488WHV94BZ496OZ3219
JSE Share Code: ISO
("ASPI" or "the Company")
ASPI TO HOST BUSINESS UPDATE CONFERENCE CALL ON APRIL 13, 2026, AT 8:00 AM ET
DALLAS, April 10, 2026 -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an
advanced materials company focused on developing technologies and processes for the production of
critical materials used in multiple industries, today announced that Paul Mann, Executive Chairman and
Chief Executive Officer at ASP Isotopes, will host a business update conference call and webcast on
Monday, April 13, 2026, at 8:00 AM ET.
Dial-in Information
USA / International Toll: +1.646.968.2525
USA - Toll-Free: +1.888.596.4144
Canada - Toronto: +1.647.495.7514
Canada - Toll-Free: +1.888.596.4144
Conference ID 5073116 and press #
Investors and the general public are invited to listen to a live webcast at:
https://events.q4inc.com/attendee/430022486
A replay of the webcast will be available at www.aspisotopes.com approximately three hours after the
conference call concludes.
About ASP Isotopes
ASP Isotopes is an advanced materials company dedicated to the development of a differentiated isotope
enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine,
next-generation semiconductors, and nuclear energy. The Company's proprietary technologies, the
Aerodynamic Separation Process ("ASP technology") and Quantum Enrichment ("QE technology"), are
designed to enable the production of isotopes for a range of industrial and advanced technology
applications. ASP Isotopes operates isotope enrichment facilities in Pretoria, South Africa, focused on the
enrichment of low atomic mass elements, or light isotopes. For more information, please visit
www.aspisotopes.com.
Forward-Looking Statements
During the business update conference call, members of management may make statements that provide
information other than historical information. Such statements are considered "forward-looking statements"
within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they
are based only on our current beliefs, expectations, and assumptions regarding the future of our business,
future plans and strategies, projections, anticipated events and trends, the economy, and other future
conditions. Forward-looking statements can be identified by words such as "believes," "plans," "anticipates,"
"expects," "estimates," "projects," "will," "may," "might," and words of a similar nature. Examples of forward-
looking statements include, among others but are not limited to: the impact of the conflict in the Middle East
and the closure of the Strait of Hormuz on the helium market; the anticipated progress and timing for
completion of Phase 1 and 2 of the Renergen helium project; the ability to fund completion of the
development of the Renergen helium project; anticipated production quantities and supply of helium and
LNG upon completion of Phase 1 and 2 of the Renergen helium project; projections about the future nuclear
fuel cycle for advanced nuclear reactors and fusion systems; the future of the company's enrichment
technologies as applied to uranium enrichment; the outcome of the company's initiative to commence
enrichment of uranium in South Africa and the company's discussions with nuclear regulators in South
Africa, the United States or the United Kingdom; the outcome of QLE's collaboration with The South African
Nuclear Energy Corporation (Necsa); the commencement of research, development and production
activities in the United States or the United Kingdom; QLE's anticipated growth strategies and anticipated
trends in QLE's business; statements relating to QLE's strategic partnerships or commercial initiatives and
relationships with Fermi America, TerraPower and Necsa; anticipated production quantities and supply of
enriched isotopes to customers; and statements we make regarding expected operating results, such as
future revenues and prospects from the potential commercialization of enriched isotopes or helium and
LNG, future performance under contracts, and our strategies for product development or extraction of
resources, engaging with potential customers, market position, and financial results. Because forward-
looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in
circumstances that are difficult to predict, many of which are outside our control. Our actual results, financial
condition, and events may differ materially from those indicated in the forward-looking statements based
upon a number of factors. Forward-looking statements are not a guarantee of future performance or
developments. You are strongly cautioned that reliance on any forward-looking statements involves known
and unknown risks and uncertainties. Therefore, you should not rely on any of these forward-looking
statements. There are many important factors that could cause our actual results and financial condition to
differ materially from those indicated in the forward-looking statements, including, but not limited to: the
outcomes of various strategies and projects undertaken by the Company; the potential impact of laws or
government regulations or policies in South Africa, the United Kingdom or elsewhere; our future capital
requirements and sources and uses of cash; our ability to obtain funding for our operations and future
growth; whether we succeed in obtaining permissions and regulatory approvals required to test and develop
our enrichment technologies on uranium in South Africa, the United Kingdom or elsewhere; our reliance on
the efforts of third parties; our ability to complete the construction and commissioning of our enrichment
plants or to commercialize isotopes using the ASP technology or the Quantum Enrichment Process; our
ability to obtain regulatory approvals for the production and distribution of isotopes; the financial terms of
any current and future commercial arrangements; our ability to complete certain transactions and realize
anticipated benefits from acquisitions and contracts; dependence on our Intellectual Property (IP) rights,
certain IP rights of third parties; the competitive nature of our industry; and the factors disclosed in Part I,
Item 1A. "Risk Factors" of the company's Annual Report on Form 10-K for the fiscal year ended December
31, 2024 and any amendments thereto and in the company's subsequent reports and filings with the U.S.
Securities and Exchange Commission. All forward-looking statements are qualified by reference to the
cautionary statements set forth herein and should not be relied upon.
Contact
IR@ASPIsotopes.com
The Company has a primary listing on the Nasdaq and a secondary listing on the Main Board of the JSE.
10 April 2026
Sponsor
Valeo Capital Proprietary Limited
Date: 10-04-2026 02:15:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
